At a glance
- Originator Roche
- Developer Nonindustrial source; Roche
- Class Antiasthmatics; Antihyperlipidaemics; Small molecules
- Mechanism of Action Apoptosis stimulants; Protein kinase C inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Asthma; Atherosclerosis; Brain cancer; Coronary artery restenosis; Transplant rejection